Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, October 1998, p. 2595-2601, Vol. 42, No. 10
Wellman Laboratories of Photomedicine,
Received 8 January 1998/Returned for modification 3 June
1998/Accepted 13 July 1998
This study explores a new approach for antimicrobial therapy with
light activation of targeted poly-L-lysine (pL)-chlorin e6 (ce6) conjugates. The goal was
to test the hypothesis that these conjugates between pL and
ce6 would efficiently target photodestruction
towards gram-positive (Actinomyces viscosus) and
gram-negative (Porphyromonas gingivalis) oral species while sparing an oral epithelial cell line (HCPC-1). Conjugates of
ce6 with pL (average molecular weight, 2,000)
having a positive, neutral, or negative charge were prepared.
Illumination with red light (
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Targeted Antimicrobial Photochemotherapy
max = 671 nm) from a diode
array produced a dose-dependent loss of CFU from the bacteria, under
conditions that did not affect the viability of the epithelial cells.
For P. gingivalis, the cationic conjugate produced 99%
killing, while the neutral conjugate killed 91% and the anionic
conjugate killed 76% after 1 min of incubation and exposure to red
light for 10 min. For A. viscosus, the cationic conjugate
produced >99.99% killing while HCPC-1 cells remained intact. The
importance of the positive charge was shown by the effectiveness of
ce6-monoethylenediamine monoamide (a
monocationic derivative of ce6) in killing both
bacteria. The clinically employed benzoporphyrin derivative under the
same conditions killed epithelial cells while leaving P. gingivalis relatively unharmed. A mixture of
ce6 with pL did not show phototoxicity
comparable with that of the cationic conjugate. These results were
explained by the selective uptake of the conjugates by bacteria (20- to
100-fold) compared to that by mammalian cells, while free
ce6 showed much less selectivity for bacteria (5- to 20-fold). The data suggest that the cationic
pL-ce6 conjugate may have an application for
the photodynamic therapy of periodontal disease.
*
Corresponding author. Mailing address: Department of
Dermatology, Massachusetts General Hospital, 50 Blossom St., WEL 224, Boston, MA 02114-2698. Phone: (617) 726-6996. Fax: (617) 726-3192. E-mail: hasan{at}helix.mgh.harvard.edu.
Antimicrobial Agents and Chemotherapy, October 1998, p. 2595-2601, Vol. 42, No. 10
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»